Skip to main navigation
Skip to search
Skip to main content
Coventry University Home
Help & FAQ
Home
Organisational Units
Profiles
Research output
Projects
Coventry awarded Student theses
Activities
Prizes
Datasets
Press/Media
Equipment
Search by expertise, name or affiliation
Healthcare outcomes: Gemcitabine cost-effectiveness in the treatment of non-small cell lung cancer
Ala Szczepura
University of Warwick
Research output
:
Contribution to journal
›
Article
›
peer-review
9
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Healthcare outcomes: Gemcitabine cost-effectiveness in the treatment of non-small cell lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Social Sciences
Cells
100%
Costs
74%
Cost-Effectiveness Analysis
74%
Study Design
74%
Therapy
74%
Economic Evaluation
74%
Legal Procedure
50%
Standards
50%
Economic Studies
50%
Decision Making
50%
Minimization
25%
Economics
25%
Research
25%
Introduction
25%
Light
25%
Health Care
25%
Information Retrieval
25%
Analysis
25%
Quality of Life
25%
Health
25%
Case Studies
25%
Nursing and Health Professions
Gemcitabine
100%
Non Small Cell Lung Cancer
74%
Cost-Minimization Analysis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Gemcitabine
100%
Chemotherapy Agent
50%
Medicine and Dentistry
Secondary Research
25%
Evaluation Research
25%
Treatment of Non-Small Cell Lung Cancer
25%